Haurwitz Rachel E.
SEC CIK 1670579 · EDGAR
BoughtSold
Most active insiders at CRBU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kelly Timothy P | CTO | — | $18.2K |
| 2 | Khan Ruhi Ahmad | Chief Business Off | — | $13.6K |
| 3 | MCCLUNG BARBARA G | CLO | — | $13.6K |
| 4 | Albertson Tina M. | Chief Medical Off | — | $2,089 |
| 5 | Ryali Sriram | CFO | — | — |
| 6 | Haurwitz Rachel E. | Pres, CEO, Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-20 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | A - Grant | $0.00 | +151.7K | 447.1K | +51% | $0 |
| I | 2025-03-17 | 2025-03-14 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | P - Purchase | $1.02 | +20.0K | 3.37M | +0.6% | +$20.4K |
| D | 2025-02-21 | 2025-02-20 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | A - Grant | $0.00 | +136.8K | 295.4K | +86% | $0 |
| 2024-06-14 | 2024-06-12 | SEER | Seer, Inc. | Haurwitz Rachel E. | Dir | A - Grant | $0.00 | +58.2K | 87.6K | +198% | $0 | |
| D | 2024-02-22 | 2024-02-20 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | A - Grant | $0.00 | +118.7K | 158.7K | +297% | $0 |
| D | 2023-06-16 | 2023-06-14 | SEER | Seer, Inc. | Haurwitz Rachel E. | Dir | A - Grant | $0.00 | +23.4K | 29.4K | +391% | $0 |
| D | 2023-06-09 | 2023-06-08 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $2.96 | +10.0K | 40.0K | +33% | +$29.6K |
| D | 2023-03-22 | 2023-03-20 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $2.96 | +10.0K | 30.0K | +50% | +$29.6K |
| D | 2022-06-17 | 2022-06-15 | SEER | Seer, Inc. | Haurwitz Rachel E. | Dir | A - Grant | $0.00 | +5,994 | 5,994 | New | $0 |
| DA | 2022-05-10 | 2022-01-26 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $2.96 | +10.0K | 10.0K | New | +$29.6K |
| D | 2022-05-10 | 2022-05-09 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $2.96 | +10.0K | 20.0K | +100% | +$29.6K |
| D | 2022-01-27 | 2022-01-26 | CRBU | Caribou Biosciences, Inc. | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $2.96 | +10.0K | 3.36M | +0.3% | +$29.6K |
Purchase Sale Sale after option exercise All abbreviations